Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prop 65

This article was originally published in The Tan Sheet

Executive Summary

California bill SB 1572, signed by Gov. Gray Davis Aug. 30, would amend Prop 65 by requiring private litigants settling any alleged violation to submit to the state AG a reporting form that includes results of the settlement, final disposition of the case. Introduced Feb. 20 by Byron Sher (D-Stanford), SB 1572 moved through the legislature without substantive amendment. Measure will supplement added controls on Prop 65 cases recently established by Sher's SB 471, enacted in October 2001. State is in the process of implementing law, which requires private litigants to produce "certificate of merit" demonstrating good cause for seeking Prop 65 warnings (1"The Tan Sheet" May 13, 2002, p. 14)...

You may also be interested in...



Prop 65 Certificate Of Merit Exposure Specificity Urged By CHPA

Certificates of merit filed with private enforcement actions under California's Proposition 65 should include specific details about the alleged toxic exposures, the Consumer Healthcare Products Association says

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094599

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel